APA (7th ed.) Citation

S, T., H, N., Y, H., S, O., H, I., T, T., . . . T, M. (2026). Clinical benefit of paclitaxel/carboplatin plus bevacizumab with zoledronic acid in pulmonary epithelioid hemangioendothelioma complicated by hypertrophic pulmonary osteoarthropathy and cardiac tamponade: A case report. Frontiers in oncology, 16, 1855346. https://doi.org/10.3389/fonc.2026.1855346

Chicago Style (17th ed.) Citation

S, Tsuchimochi, et al. "Clinical Benefit of Paclitaxel/carboplatin Plus Bevacizumab with Zoledronic Acid in Pulmonary Epithelioid Hemangioendothelioma Complicated by Hypertrophic Pulmonary Osteoarthropathy and Cardiac Tamponade: A Case Report." Frontiers in Oncology 16 (2026): 1855346. https://doi.org/10.3389/fonc.2026.1855346.

MLA (9th ed.) Citation

S, Tsuchimochi, et al. "Clinical Benefit of Paclitaxel/carboplatin Plus Bevacizumab with Zoledronic Acid in Pulmonary Epithelioid Hemangioendothelioma Complicated by Hypertrophic Pulmonary Osteoarthropathy and Cardiac Tamponade: A Case Report." Frontiers in Oncology, vol. 16, 2026, p. 1855346, https://doi.org/10.3389/fonc.2026.1855346.